Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
Process for preparation of midostaurin 2020-6-23 2022-8-04
Ctla4-ig fusion protein formulation 2019-5-24 2021-6-17
Antibody formulation 2019-4-10 2021-5-20
Process for preparation of obeticholic acid 2017-5-31 2020-10-08
Amine salt of obeticholic acid 2017-2-10 2021-6-24
Method for reduction of aggregates 2015-12-21 2016-6-30
Mab-fcrn assay 2015-4-02 2015-12-17
Liquid pharmaceutical formulations of pemetrexed 2014-12-19 2017-5-11
Process for the preparation of suvorexant and intermediates useful in the … 2014-7-15 2016-6-16
Refolding of proteins 2014-3-28 2016-2-04
Synthetic heparin pentasaccharides 2014-1-29 2016-1-26 2016-1-26
Diastereoselective process for preparing statin intermediates 2013-6-21 2013-8-07
Substituted heterocyclic acetamides as kappa opioid receptor (kor) agonists 2013-3-05 2015-1-29
Processes for the production of a lactone statin intermediate by enzymatic … 2012-11-06 2013-5-16
Production of enantiomerically purified amino acids 2012-4-10 2014-2-19
Method for analyzing activated polyethylene glycol compounds 2011-10-25 2012-5-24
Use of storage stable viscous phospholipid depot to treat wounds 2011-10-18 2019-6-04 2019-6-04
Kappa opioid receptor agonists 2011-7-19 2013-11-14
Enhanced protein expression 2011-1-06 2011-7-14
Phospholipid depot 2010-12-17 2017-1-03 2017-1-03
Balaglitazone compositions and methods 2010-12-17 2013-5-02
LENALIDOMIDE PREPARATION 2010-10-11 2010-11-30
Processes for preparing pemetrexed 2010-8-09 2011-6-01
PREPARATION OF HYDROCLORIDE OF PALONOSETRON CRISTALINO 2009-11-11 2011-1-05
Process for preparing simvastatin 2008-8-15 2009-2-19
O-desmethylvenlafaxine 2008-7-10 2009-1-15
Esomeprazole salts and processes for preparation thereof 2008-5-09 2008-12-10
Novel aldehyde composition 2008-4-23 2010-7-28
Method of producing amino dialkoxy aldehydes via hydroformylation 2008-4-23 2010-7-14
A process for the preparation of rivastigmine or a salt thereof 2008-4-10 2008-10-29
IMATINIB MESILATE 2008-3-12 2014-9-02
Modified-release formulations of calcium receptor-active compounds 2007-11-20 2008-10-30
Methods for preparing cinacalcet hydrochloride 2007-11-08 2008-8-28
Preparation of montelukast and its salts 2007-11-06 2008-7-10
Chelating agents with lipophilic carriers 2007-10-09 2008-6-19
A process for the preparation of benzimidazole derivatives and their salts 2007-10-05 2008-4-17
Antihistamine-decongestant combinations 2007-10-04 2008-4-10
SPECIFIC HYDROLYSIS OF THE UNPROTECTED (R) -ESTERS OF (3) -AMINO-3- … 2007-10-02 2011-1-27
Atorvastatin pharmaceutical compositions 2007-9-27 2008-4-03
Dipyridamole pharmaceutical compositions 2007-8-29 2008-3-05
Bicalutamide compositions 2007-8-16 2008-2-21
Pharmaceutical compositions comprising amorphous benzimidazole compounds 2007-7-02 2008-8-27
Topical compositions 2007-6-14 2009-4-08
Use of biomarkers of inflammation as indicators of drug efficacy 2007-5-25 2008-4-17
5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin and its preparation and use for the … 2007-5-24 2008-3-27
Preparation of loratadine form i 2007-4-04 2008-8-14
Preparation of ramipril and stable pharmaceutical compositions 2007-4-04 2007-10-04
Aprepitant polymorph mixtures 2007-3-29 2008-10-09
docetaxel polymorphs and processes 2007-3-20 2011-6-14
METHOD FOR PRODUCING POLYETHYLENE GLYCOL CARBONATES 2007-2-27 2010-9-09
gemcitabine preparation 2007-2-06 2011-5-10
Crystalline forms of perindopril erbumine 2007-2-02 2007-8-16
Preparation of atorvastatin calcium form vi and compositions thereof 2007-1-30 2008-2-28
Primidone process and compositions 2006-12-19 2007-6-28
Non-benzodiazepine hypnotic compositions 2006-10-26 2007-5-03
Galantamine compositions 2006-10-10 2007-4-26
Cetirizine compositions 2006-10-06 2007-4-19
Anti-inflammatory pharmaceutical composition 2006-9-21 2007-9-27
Process to prepare amino acid derivatives 2006-9-20 2009-4-15 2009-4-15
Medical devices employing triazine compounds and compositions thereof 2006-8-30 2007-5-31
Methods and compositions of novel triazine compounds 2006-8-28 2007-5-24
Stable desloratadine compositions 2006-7-12 2007-1-18
Extended release compositions 2006-7-06 2007-1-11
Process for making diphosphine-ruthenium-diamine complexes 2006-6-28 2009-12-30 2009-12-30
Stable desloratadine compositions 2006-5-19 2007-1-04
Asymmetric hydrogenation for the preparation of diphenylalanine derivatives 2006-5-09 2010-9-22 2010-9-22
Pharmaceutical compositions having a swellable coating 2006-1-12 2006-2-28
Methods and compositions of novel triazine compounds 2005-11-22 2006-8-03
Process for preparing tolterodine 2005-10-26 2006-5-04
Amorphous atorvastatin calcium 2005-9-30 2006-6-16
Process for making polyethylene glycol compounds 2005-9-27 2012-4-04 2012-4-04
Crystalline form of oxcarbazepine 2005-7-15 2006-7-27
Processes to produce intermediates for rosuvastatin 2005-6-21 2006-1-05
Hydroformylation process for pharmaceutical intermediate 2005-4-26 2009-11-11 2009-11-11
Steroid extraction process from urine sources 2005-2-10 2013-1-08 2013-1-08
Method of treatment for improved bioavailability 2005-1-18 2005-7-07
Method for preparing diaryl-substituted isoxazole compounds 2004-12-29 2005-8-18
Pharmaceutical composition 2004-12-23 2007-6-21
Compositions comprising balaglitazone and further antidiabetic compounds 2004-6-24 2005-1-06
Crystalline form III of anhydrous moxifloxacin hydrochloride and a process for … 2004-4-09 2007-6-12 2007-6-12
Triazine compounds and their analogs, compositions, and methods 2004-3-24 2005-10-13
Crystalline form Z of rabeprazole sodium and process for preparation thereof 2004-2-25 2004-9-16
Polymorphic forms of dihydrochloride salts of cetirizine and processes for … 2003-12-04 2004-6-17
Amorphous hydrates of esomeprazole magnesium and process for the preparation … 2003-8-28 2005-6-29
Amorphous form of (-)-[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1- piperazinyl] … 2003-6-23 2004-7-08
Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-( … 2003-4-07 2006-6-29
Crystalline forms of rabeprazole sodium 2003-3-25 2005-10-20
ENZYMATIC RACEMATING OF PROPYLENE GLYCOL ALKYL (OR ARYL -) ETHERS AND ETHER … 2003-3-21 2010-7-08 2010-7-08
Novel crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl] … 2003-3-14 2005-10-20
Novel pharmaceutical compositions for antihistaminic-decongestant combination … 2002-4-04 2006-8-17
Novel tablets and capsules and a process for its preparation 2002-3-12 2003-3-13
Novel polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino]ethoxy]benzyl] … 2001-9-25 2005-4-28
Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1- … 2001-7-31 2002-12-27
Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1- piperidinyl]-1- … 2001-7-31 2004-4-22
Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst … 2001-6-19 2002-3-14
Pharmaceutical composition and the process for its preparation 2001-5-23 2004-3-23 2004-3-23
Process for preparation of hydrates of olanzapine and their conversion into … 2001-3-07 2005-9-28
Compounds having antitumor activity: process for their preparation and … 2001-2-02 2005-4-28
Patent IN190899B 2000-10-19 2003-8-30
New pharmaceutical composition and the process for its preparation 2000-5-30 2001-12-06